Senior Director of Development
Paul has worked in the radiopharmaceutical industry for 30 years, beginning his career in 1989 at DuPont Radiopharmaceuticals where he spent time in both the Research and Development groups. He joined Pharmalucence in 1999 as the Manager of Technology Transfer, responsible for the oversight of all raw material and final product contract manufacturing. In 2002 he began building a Development team focusing on generic radiopharmaceuticals. Over his 20 years at Pharmalucence Paul and his team have successfully developed and commercialized several generic products, and have optimized several other existing products. His team consists of both process and analytical development scientists, specializing in formulation, lyophilization and method development/validation. More recently as part of Sun Pharmaceuticals, Paul and his team have assisted in the development of other types of generic pharmaceutical products including injectable therapeutics and ophthalmics. His team works closely with the Manufacturing, Quality and Regulatory departments both locally at Pharmalucence and globally within the Sun organization.